Venezuela’s president, Nicolás Maduro, said this Sunday that his country will publish “in the coming days” the investigations carried out into the drug Carvativir, which the president himself says is complementary to treatments against the SARS-COV. -2 virus, which causes covid-19.
“A brutal campaign has been unleashed against Carvativir, it is an antiviral, it helps as an antiviral to stop, neutralize the coronavirus cell,” Maduro said during the weekly review of the fight against Covid-19 in Venezuela. .
“It has been scientifically proven, we have the study (s) in the coming days, the international scientific publication will be conducted with all Carvativir studies,” he added.
PAHO ASKED TO PUBLISH STUDIES
Last Wednesday, the Pan American Health Organization (PAHO) requested publication of the findings on Carvativir, a drug developed in Venezuela that Maduro defended days earlier as ‘miracle drops’ that neutralize the coronavirus 100%.
However, Maduro corrected his original statements, which he acknowledged had sparked “huge controversy” and later noted that Carvativir is “complementary” in the treatments against covid-19.
Today, the president said the doubts raised by the drug are based on “the envy” and “selfishness” of world powers and major pharmaceutical companies.
“(Because of) the dirty minds of some, it occurs to them to use ideological and political criteria to fight the cause of science,” he added.
“ENCOURAGING” RESULTS
Venezuela’s Science Minister Gabriela Jiménez – who joined Maduro on his day today – said a Venezuelan scientific research institute was conducting the first studies on the drug, which were completed in two private labs abroad.
“The results (of the studies) showed that patients showed a modulating effect with Carvativir,” said Jiménez. “The results are encouraging and the articles are already available,” he added.
MASS PRODUCTION OF DRUG
Last week, Maduro indicated that his government will immediately begin “mass production” of this drug, for which it plans to establish a direct distribution system that will ensure the arrival of doses to all hospitals and health centers in general.
In addition, he said he estimates that he exports thousands of doses of Carvativir to the countries that make up the ALBA-TCP block along with Venezuela (Cuba, Nicaragua, Bolivia, Haiti and other Caribbean countries) and commercializes this with other countries with which it services a “strategic relationship,” although he did not mention one.
In this sense, ALBA-TCP general secretary Sacha Llorenti said in an interview broadcast on Venezuelan public television this Sunday that Carvativir is “a sign of hope” in the fight against Covid-19 in the region., And that he hope will be produced in a massive way.